Antibody-based nanoprobe for measurement of a fluorescent analyte in a single cell

We report here the application of an antibody-based nanoprobe for in situ measurements of a single cell. The nanoprobe employs antibody-based receptors targeted to a fluorescent analyte, benzopyrene tetrol (BPT), a metabolite of the carcinogen benzo[a]pyrene (BaP) and of the BaP-DNA adduct. Detectio...

Full description

Saved in:
Bibliographic Details
Published inNature biotechnology Vol. 18; no. 7; pp. 764 - 767
Main Authors Vo-Dinh, Tuan, Alarie, Jean-Pierre, Cullum, Brian M, Griffin, Guy D
Format Journal Article
LanguageEnglish
Published New York, NY Nature 01.07.2000
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We report here the application of an antibody-based nanoprobe for in situ measurements of a single cell. The nanoprobe employs antibody-based receptors targeted to a fluorescent analyte, benzopyrene tetrol (BPT), a metabolite of the carcinogen benzo[a]pyrene (BaP) and of the BaP-DNA adduct. Detection of BPT is of great biomedical interest, since this species can serve as a biomarker for monitoring DNA damage due to BaP exposure and for possible precancer diagnosis. The measurements were performed on the rat liver epithelial clone 9 cell line, which was used as the model cell system. Before making measurements, the cells were treated with BPT. Nanoprobes were inserted into individual cells, incubated 5 min to allow antigen-antibody binding, and then removed for fluorescence detection. We determined a concentration of 9.6+/-0.2x10(-11) M for BPT in the individual cells investigated. The results demonstrate the possibility of in situ measurements inside a single cell using an antibody-based nanoprobe.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1087-0156
1546-1696
DOI:10.1038/77337